Amy C. Sherman, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection (NCT03728426) | Amy C. Sherman, MD | 2019-01-11 |
Track Amy C. Sherman, MD automatically
Every clearance here is in the API, with alerts when new ones post.